SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : (INNV) MC $5 M /Float 3.3 M /2x Big Product Launchs imminent

 Public ReplyPrvt ReplyMark as Last ReadFilePreviousNext  
From: BioHero9/24/2013 7:01:06 AM
   of 1
 
Fantastic News out today and in the last few days the CEO is doing really a good job here . Dont forget his main goal is the Nasdaq Listing within 2014 and a requirement to get the Nasdaq Listing is the Stock must be above $3 so it means that he sees this stock moving higher than $3 which would mean a low market cap of around $54 Million .GL

Current Price : $1.05
--

Innovus Pharma Readies the Launch of EjectDelay(TM) for Premature Ejaculation With Nationwide Sampling Program to Urologists in the U.S. Through the American Urology Association...Sept. 24, 2013
finance.yahoo.com

Innovus Pharma Signs Second License and Distribution Agreement With Ovation Pharma for EjectDelay(TM) in Morocco
Company to Receive Up to $18.6 Million in Payments
finance.yahoo.com

Innovus Pharma Signs License and Distribution Agreement With Ovation Pharma for CIRCUMserum(TM) in Morocco
Company to Receive up to $11.25 Million in Milestone Payments
finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePreviousNext